NCT01528124View on ClinicalTrials.gov

A Study of LY3025876 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

LY3025876

Given as a subcutaneous injection

DRUG

Placebo

Given as a subcutaneous injection

Trial Locations (1)

117597

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01528124 - A Study of LY3025876 in Healthy Volunteers | Biotech Hunter | Biotech Hunter